Back to News
Market Impact: 0.65

Williams-Sonoma stock price target raised to $39 from $38 at RBC Capital

RYWSMARISKEYUBSBCS
Corporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsCompany FundamentalsM&A & RestructuringProduct LaunchesConsumer Demand & Retail
Williams-Sonoma stock price target raised to $39 from $38 at RBC Capital

Williams-Sonoma (WSM) has seen multiple analysts, including KeyBanc, UBS, RBC Capital, and Barclays, recently raise their price targets following the company's stronger-than-expected Q2 2025 earnings and reaffirmed full-year guidance. This positive sentiment is further supported by WSM's strong balance sheet, strategic acquisition of Aris to bolster water solutions, and robust transaction data, contributing to its impressive 49% return over the past year and solidifying its position within the home furnishings sector.

Analysis

Williams-Sonoma (WSM) is experiencing a wave of positive analyst sentiment following second-quarter 2025 earnings that surpassed consensus estimates. This performance prompted the company to reaffirm its full-year 2025 guidance, lending stability to its outlook and bolstering investor confidence. Consequently, multiple investment firms have raised their price targets, including KeyBanc to $230 (Overweight), RBC Capital to $212, UBS to $184 (Neutral), and Barclays to $180 (Equalweight). The rationale behind these upgrades is rooted in strong underlying business trends, with analysts citing robust transaction data and forecasting above-consensus comparable sales growth of 3.6% to 4.0%. This operational strength is occurring against a backdrop of significant stock momentum, evidenced by a 49% return over the past year and a current P/E ratio of 22.6x. The company's strategic initiatives, such as the West Elm brand's collection expansion with designer Joseph Altuzarra, further underscore its efforts to maintain a strong position in the home furnishings sector.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo